Jameel Abdulrehman

Dr. Jameel Abdulrehman, a hematologist at the University of Toronto, dives into the intricate world of venous thromboembolism (VTE) management. He discusses the latest CHEST Guidelines and compares direct oral anticoagulants to traditional therapies like warfarin. The conversation highlights risk assessment strategies, emphasizing gender-specific responses to anticoagulation. Abdulrehman also sheds light on extended anticoagulation for cancer-related thrombosis and managing superficial vein thrombosis, showcasing the complexities of treatment decisions.

Dr. Jameel Abdulrehman, a Hematologist and Assistant Professor at University of Toronto, discusses the latest recommendations in VTE treatment. Topics include comparing DO-ACs and warfarin, treatment durations, extended anti-coagulation in VTE patients, and VTE management in pregnancy and postpartum.